Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.2 EUR | 0.00% | -0.89% | -1.33% |
Apr. 18 | PharmaSGP Holding SE Proposes Dividend for the Financial Year 2023 | CI |
Apr. 18 | PharmaSGP Holding SE Announces Changes to Dividend Policy | CI |
Sales 2023 * | 98.7M 106M | Sales 2024 * | 106M 113M | Capitalization | 266M 285M |
---|---|---|---|---|---|
Net income 2023 * | 14M 14.97M | Net income 2024 * | 16M 17.11M | EV / Sales 2023 * | 2.71 x |
Net Debt 2023 * | 1.05M 1.12M | Net cash position 2024 * | 12.85M 13.74M | EV / Sales 2024 * | 2.39 x |
P/E ratio 2023 * |
18
x | P/E ratio 2024 * |
16
x | Employees | 79 |
Yield 2023 * |
2.5% | Yield 2024 * |
2.79% | Free-Float | 18.52% |
1 week | -0.89% | ||
Current month | +1.37% | ||
1 month | +1.37% | ||
3 months | -0.45% | ||
6 months | +7.25% | ||
Current year | -1.33% |
Managers | Title | Age | Since |
---|---|---|---|
Natalie Weigand
CEO | Chief Executive Officer | 43 | 16-12-31 |
Michael Rudolf
DFI | Director of Finance/CFO | 50 | 16-12-31 |
Lara Mögenburg
HRO | Human Resources Officer | - | 20-02-29 |
Members of the board | Title | Age | Since |
---|---|---|---|
Axel Rebien
BRD | Director/Board Member | 52 | 20-05-31 |
Clemens Fischer
CHM | Chairman | 49 | 20-03-03 |
Director/Board Member | 43 | 20-03-03 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 22.2 | 0.00% | 179 |
24-04-25 | 22.2 | 0.00% | 314 |
24-04-24 | 22.2 | +1.83% | 1,345 |
24-04-23 | 21.8 | +0.93% | 142 |
24-04-22 | 21.6 | -3.57% | 748 |
Delayed Quote Xetra, April 26, 2024 at 11:36 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.33% | 284M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- PSG Stock